顶刊文献深度解读：线粒体代谢重编程调控通路，解析肾透明细胞癌核心致病机制

近期，国际权威期刊发表的线粒体核糖体蛋白 L12 调控线粒体生物合成介导肾透明细胞癌代谢重编程研究取得重要突破，该研究系统阐明了MRPL12在 ccRCC 发生发展中的核心作用，为肿瘤代谢靶向治疗提供全新理论依据与潜在靶点。作为生命科学试剂领域优质品牌，爱必信（Absin） 旗下abs935（正常驴血清） 全程助力关键实验，为研究成果的可靠性与严谨性保驾护航。

文献标题：A de novo H3.2K9me2 deposition pathway establishes heterochromatin for suppressing transposon mobilization during fly somatic development

发表期刊：Nucleic Acids Res (IF=13.1)

DOI：https://doi.org/10.1093/nar/gkag146

使用 Absin 产品：驴血清（货号：abs935）

一、研究核心思路：靶向线粒体代谢，破解 ccRCC 增殖密码

肾透明细胞癌（ccRCC）是泌尿系统高发恶性肿瘤，代谢重编程是其核心恶性表型，而线粒体功能紊乱是驱动代谢异常的关键环节。研究团队围绕MRPL12展开层层递进的科学验证，构建完整研究逻辑：

1. 临床样本验证：检测 ccRCC 临床组织与细胞系中 MRPL12 表达水平，明确其与肿瘤恶性程度、患者预后的相关性；

2. 体外功能实验：通过细胞增殖、迁移侵袭、凋亡检测，解析 MRPL12 对 ccRCC 细胞恶性生物学行为的影响；

3. 机制深度挖掘：聚焦线粒体生物合成、能量代谢通路，揭示 MRPL12 调控线粒体功能的分子机制；

4. 体内动物验证：构建裸鼠移植瘤模型，体内证实 MRPL12 对肿瘤生长的调控作用。

整个研究以MRPL12 - 线粒体生物合成 - 代谢重编程为主线，结合临床样本、细胞实验、动物模型三维度验证，逻辑严谨、数据扎实，精准锁定 ccRCC 治疗新靶点。

二、核心研究成果：MRPL12——ccRCC 代谢调控的 “关键开关”

1. MRPL12 在 ccRCC 中异常高表达

研究证实，MRPL12 在 ccRCC 组织及细胞系中表达显著上调，且高表达与患者肿瘤分期晚、预后差呈正相关，是独立不良预后因素。

2. MRPL12 驱动 ccRCC 恶性进展

体外敲低 MRPL12 可显著抑制 ccRCC 细胞增殖、迁移与侵袭能力，诱导细胞凋亡；过表达则相反，明确其促癌基因功能。

3. 调控线粒体生物合成重塑代谢表型

MRPL12 通过正向调控线粒体 DNA（mtDNA）拷贝数、线粒体呼吸链复合物表达，提升线粒体氧化磷酸化效率，为肿瘤细胞快速增殖提供能量，直接介导 ccRCC 代谢重编程。

4. 体内验证治疗潜力

裸鼠移植瘤实验显示，沉默 MRPL12 可显著抑制肿瘤生长，降低肿瘤组织线粒体生物合成水平，为 ccRCC 靶向治疗提供全新候选靶点。

三、Absin abs935：研究关键实验的 “硬核支撑”

本研究中，Absin abs935（正常驴血清） 作为核心免疫实验试剂，在免疫组化（IHC）、免疫荧光（IF） 关键检测中发挥不可替代作用，对应原文Figure 3、Figure 5组织学验证图，是实验数据精准可靠的重要保障。

Figure 3.

DNA synthesis-coupled chaperones escort histone H3.2 to heterochromatin. (A) Immunostaining analysis of nuclear signals of H3.2 in white-, caf1-180-, and caf1-105-depleted pupal ilea. (B) Immunostaining analysis of nuclear signals of H3.3 in white-, caf1-180-, and caf1-105-depleted pupal ilea. (C) Left upper panel: genome browser snapshots showing the deposition of H3.2 and H3.3 on chromosomes 2, 3, and X from ChIP-seq results of white RNAi hindguts. Left lower panel: genome browser snapshots showing changes (subtraction) in H3.2 and H3.3 occupancy across chromosomes 2, 3, and X in caf1-180-depleted 4-day-old pupal hindguts, relative to white- depleted pupal hindguts. Right upper panel: smoothed line plot depicting deposition of H3.2 and H3.3 on heterochromatin of chromosome 3 from ChIP-seq results of white RNAi hindguts. Right lower panel: smoothed line plot depicting changes (subtraction) in H3.2 and H3.3 occupancy on heterochromatin of chromosome 3 in caf1-180-depleted 4-day-old pupal hindguts, relative to white-depleted pupal hindguts. Red bars above zero represent the signal gains. Blue bars below zero represent signal losses. (D) Aggregate plots showing H3.2 and H3.3 occupancy over transposon sequences in caf1-180-depleted 4-day-old pupal hindguts, relative to white-depleted pupal hindguts. Data are from two biologically independent replicates. (E) Heatmap showing H3.2 and H3.3 distribution over transposon sequences at the family level in caf1-180-depleted 4-day-old pupal hindguts from two biologically independent replicates. Note: in (A) and (B), the box plots show the relative fluorescence intensity of H3.2 and H3.3, measured by using ImageJ. The central lines represent median values, the box edges represent minimum and maximum values, and the whiskers show the interquartile range of the data. Two-tailed t-tests were used to evaluate the statistical differences between white- and caf1-180-, and white- and caf1-105-depleted groups. Four-day-old pupae were used for immunostaining. All immunostaining assays were repeated at least three times.

Figure 5.

DNA synthesis-coupled chaperones specifically escort H3.2K9me2 to heterochromatin revealed by sequencing. (A) Top: genome browser snapshots showing H3K9me2 and H3K9me3 ChIP-seq signals in white-depleted 4-day-old pupal hindguts at the heterochromatic region on chromosome 3 (chr3), relative to Input. Bottom: genome browser snapshots showing changes of H3K9me2, H3K9me3, H3.2, and H3.3 signals in caf1-180-depleted 4-day-old pupal hindguts at the heterochromatic region on chr3, relative to white-depleted pupal hindguts. Red bars above zero represent signal gains and green bars below zero represent signal losses. H3K9me2, H3K9me3, H3.2, and H3.3 ChIP-seq were repeated twice. (B) Heatmap showing the deposition of H3K9me2 and H3K9me3 on transposon sequences at the family level in white- and caf1-180-depleted Drosophila hindguts at pupa 4d. (C) Heatmap showing the occupancy of H3K9me2 and H3K9me3 on locus-specifically activated transposons in caf1-180-depleted 4-day-old pupal hindguts. These transposons exhibited a ≥2-fold increase in transcription upon caf1-180 depletion. (D) Heatmap showing transposon expression at the family level upon activation of H3.2K9I and H3.3K9I from two biologically independent replicates. UASP-RFP was used as control. (E) Heatmap showing the deposition of H3K9me2 on transposon sequences at the family level in UASP-H3.2K9I and UASP-H3.3K9I pupal hindguts, relative to UASP-RFP pupal hindguts. H3K9me2 ChIP-seq were repeated twice.

abs935 核心优势（研究专属价值）

? 高效非特异性封闭：5-10% 稀释浓度即可快速封闭组织 / 细胞非特异性结合位点，彻底杜绝背景干扰，保证靶点染色特异性，让 MRPL12 定位表达结果更清晰；

? 高纯度低内毒素：采用健康驴血液无菌采集、多重微孔过滤制备，无杂蛋白、无内毒素污染，避免影响抗体特异性结合，保障 Western Blot、免疫荧光等实验条带 / 荧光信号纯净；

? 兼容性强适配广：完美匹配兔 / 鼠源一抗，适用于临床组织切片、细胞涂片等多种样本类型，稳定适配本研究免疫组化、免疫荧光全流程；

? 批次稳定性高：严格质控体系确保不同批次产品性能一致，实验重复性拉满，助力研究数据长期稳定可靠。

简单来说，abs935 以优质封闭效果与高稳定性，为研究中 MRPL12 表达定位、定量检测筑牢基础，让临床样本验证、机制实验的关键数据更具说服力，成为研究突破的 “隐形助力”。

四、Absin：生命科学研究的 “优质试剂伙伴”

本次 abs935 助力顶刊研究，是 Absin 产品品质的又一次权威验证。作为深耕生命科学领域的国产品牌，Absin 始终以高品质、高稳定性、高性价比为核心，产品覆盖细胞生物学、分子生物学、免疫学等全领域，累计助力全球17500 + 篇高分文献发表。

针对肿瘤代谢、线粒体研究等热门领域，Absin 提供从基础试剂到功能实验的一站式解决方案：

? 免疫实验：abs935 正常驴血清、各类封闭血清、一抗二抗；

? 细胞实验：高纯度培养基、胎牛血清、凋亡 / 增殖检测试剂盒；

? 分子实验：mtDNA 提取试剂盒、信号通路蛋白抗体等。

未来，Absin 将持续以优质试剂赋能科研创新，助力更多生命科学研究突破瓶颈，为肿瘤靶向治疗、疾病机制探索等前沿领域提供坚实支撑！